XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 93 filers reported holding XENON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $397,042 | +12.2% | 11,623 | +26.4% | 0.00% | 0.0% |
| Q2 2023 | $353,931 | +6.3% | 9,193 | -1.2% | 0.00% | 0.0% |
| Q1 2023 | $333,098 | -10.5% | 9,307 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $372,180 | +54.4% | 9,439 | +41.6% | 0.00% | +100.0% |
| Q3 2022 | $241,000 | +18.7% | 6,667 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $203,000 | -1.5% | 6,667 | -1.0% | 0.00% | 0.0% |
| Q1 2022 | $206,000 | -31.1% | 6,733 | -29.6% | 0.00% | 0.0% |
| Q4 2021 | $299,000 | +367.2% | 9,565 | +127.7% | 0.00% | – |
| Q3 2021 | $64,000 | -15.8% | 4,201 | +2.7% | 0.00% | – |
| Q2 2021 | $76,000 | +4.1% | 4,091 | 0.0% | 0.00% | – |
| Q1 2021 | $73,000 | – | 4,091 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |